|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent INSP insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why INSP insider buys are important for investors to follow.
Date | Insider | Price | Amount |
10-12-2023 Insider Buy |
Charisse Y. Sparks Chief Medical Officer |
$153.50
CAGR »
|
$15,350.00 100 shares |
5-7-2018 Insider Buy |
Marilyn C. Nelson Director |
$16.00
CAGR »
|
$1,000,000.00 62,500 shares |
5-7-2018 Insider Buy |
Dana G. Mead Jr. Director |
$16.00
CAGR »
|
$320,000.00 20,000 shares |
5-7-2018 Insider Buy |
Casey M. Tansey Director and >10% Owner |
$16.00
CAGR »
|
$3,000,000.00 187,500 shares |
5-7-2018 Insider Buy |
Amzak Health Investors, LLC >10% Owner |
$16.00
CAGR »
|
$2,000,000.00 125,000 shares |
5-7-2018 Insider Buy |
Shawn McCormick Director |
$16.00
CAGR »
|
$48,000.00 3,000 shares |
5-7-2018 Insider Buy |
ORBIMED ADVISORS LLC >10% Owner |
$16.00
CAGR »
|
$5,000,000.00 312,500 shares |
5-7-2018 Insider Buy |
Chau Quang Khuong Director and >10% Owner |
$16.00
CAGR »
|
$5,000,000.00 312,500 shares |
5-7-2018 Insider Buy |
Steven Jandrich Chief Comp Off & VP, Human Res |
$16.00
CAGR »
|
$32,800.00 2,050 shares |
5-15-2012 Insider Buy |
William J. Ruckelshaus President and CEO |
$13.49
CAGR »
|
$47,215.00 3,500 shares |
11-23-2011 Insider Buy |
Andrew Miles Snyder Director |
$8.35
CAGR »
|
$133,583.30 15,998 shares |
11-22-2011 Insider Buy |
Andrew Miles Snyder Director |
$8.40
CAGR »
|
$2,394.00 285 shares |
11-21-2011 Insider Buy |
Andrew Miles Snyder Director |
$8.46
CAGR »
|
$239,557.56 28,300 shares |
11-17-2011 Insider Buy |
Andrew Miles Snyder Director |
$8.61
CAGR »
|
$617,489.00 71,700 shares |
Also See: Institutional Holders of INSP
Also See: SEC filings
Below we present the annualized performance delivered by INSP stock since 10-12-2023 (the date of the most recent
insider purchase). The performance of the investment from the time INSP insider buying occurred is the ultimate
test of whether insiders were right about INSP being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
10/13/2023 |
|
End date: |
04/18/2024 |
|
Start price/share: |
$150.47 |
|
End price/share: |
$241.15 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
60.26% |
|
Annualized Gain: |
117.00% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$16,026.00 |
|
Years: |
0.52 |
|
INSP Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent INSP insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding INSP
|
|